Just a moment...
We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic
• Quick overview summary answering your query with references
• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced
• Includes everything in Basic
• Detailed report covering:
- Overview Summary
- Governing Provisions [Acts, Notifications, Circulars]
- Relevant Case Laws
- Tariff / Classification / HSN
- Expert views from TaxTMI
- Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.
Help Us Improve - by giving the rating with each AI Result:
Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
Select multiple courts at once.
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
<h1>Notification No. 1/93-C.E. covers any name, mark or writing showing product-company connection; relief granted, penalty deleted</h1> The SC held the Tribunal erred in denying Notification No. 1/93-C.E. relief, finding that any name, mark or writing (including a company name) used to ... Brand name or trade name - that is to say qualification of a statutory explanation - use of another company's name indicating a connection in the course of trade - entitlement to exemption under the notification conditioned on absence of such association - penalty under Rule 173Q of the Central Excise Rules - discretion to impose or deleteBrand name or trade name - use of another company's name indicating a connection in the course of trade - entitlement to exemption under the notification conditioned on absence of such association - Use of the name of a well-known cement manufacturer on the product disentitles the manufacturer to the benefit of the Notification - HELD THAT: - The Explanation qualifying 'brand name or trade name' by the words 'that is to say' must be read to include a 'name or a mark' such as a symbol, monogram, label, signature, invented word or 'any writing' when used in relation to the product for the purpose of indicating a connection in the course of trade between the product and some other person. Where, as here, the manufacturer printed on the bags 'A Subsidiary of Grasim Industries Ltd.' with the admitted purpose of indicating a connection between the cement and the well-known Grasim company, that use falls within the Explanation and thereby disentitles the manufacturer to the Notification benefit. The Tribunal's contrary approach (treating mere company-name indication as outside the Explanation) misconstrued the statutory wording and was therefore erroneous. [Paras 11, 12, 13]Tribunal's allowance was set aside; the Respondents are not entitled to the benefit of the Notification because they used the name of another company to indicate a trade connection.That is to say qualification of a statutory explanation - brand name or trade name - Astra Pharmaceuticals (interpreting 'patent or proprietary medicines') does not support the Tribunal's view and was misapplied - HELD THAT: - The Court explained that the Astra Pharmaceuticals decision concerned the phrase 'patent or proprietary medicines' and its Explanation (which required brand names or registered trade marks in that context) and thus is contextually different. The Explanation in the Notification under challenge uses 'brand name or trade name' qualified by 'that is to say' and expanded to include unregistered names, marks or writings; consequently, Astra Pharmaceuticals is not authoritative for the statutory construction required here and the Tribunal's reliance on it amounted to misconstruction. [Paras 11, 12]Astra Pharmaceuticals was misapplied by the Tribunal and does not support excluding the use of another company's name from the Explanation's ambit.Brand name or trade name - that is to say qualification of a statutory explanation - Earlier Tribunal decisions adopting the contrary interpretation are erroneous and are overruled to the extent they conflict with the Court's interpretation - HELD THAT: - Decisions of the Tribunal (including Nippa Chemicals, Christine Hoden, Sarat Electronics and others) that treated mere indication of another company's name as falling outside the Explanation were based on an unduly narrow reading, including reliance on dictionary meanings of 'writing,' and thus misdirected. The Court held that the statutory phraseology is wide enough to include the name of another company when used to indicate a commercial connection, so those Tribunal precedents are incorrect and cannot be followed. [Paras 15, 16, 17, 18]Tribunal precedents taking the opposite view are disapproved to the extent inconsistent with this judgment.Penalty under Rule 173Q of the Central Excise Rules - discretion to impose or delete - Imposition of penalty under Rule 173Q deleted despite finding of ineligibility for Notification - HELD THAT: - Although the Commissioner correctly concluded that the respondents were not entitled to the Notification, the Court noted that the Tribunal had repeatedly taken the alternative (erroneous) view, and it was therefore possible for the respondents to have reasonably concluded they were entitled to the exemption. Given that state of conflicting authorities and the bona fides of the respondents' position, the Court exercised its discretion to remove the penalty imposed under Rule 173Q. [Paras 20]Penalty imposed under Rule 173Q is deleted.Final Conclusion: Appeals allowed in part; the Tribunal's judgment is set aside and the Commissioner's order denying the Notification benefit is restored, but the penalty under Rule 173Q is deleted. No order as to costs. Issues Involved:1. Entitlement to the benefit of Notification No. 5/98-C.E., dated 2nd June, 1998.2. Interpretation of 'brand name' or 'trade name' under the Notification.3. Consistency of Tribunal's previous judgments with Supreme Court decisions.4. Imposition of penalty under Rule 173Q of the Central Excise Rules, 1944.Detailed Analysis:1. Entitlement to the Benefit of Notification No. 5/98-C.E., dated 2nd June, 1998:The core issue was whether the Respondents were entitled to the benefit of Notification No. 5/98-C.E., which provided certain excise duty exemptions. The Respondents used the name 'Grasim Industries Ltd.' on their cement bags, which led to a dispute on whether this constituted the use of a 'brand name' or 'trade name' of another company, thus disqualifying them from the exemption.2. Interpretation of 'Brand Name' or 'Trade Name' Under the Notification:The Notification's explanation clarified that a 'brand name' or 'trade name' could be registered or unregistered and included any name, mark, symbol, monogram, label, signature, or invented word used to indicate a connection in the course of trade between the product and some person. The Supreme Court found that the use of 'Grasim Industries Ltd.' by the Respondents was intended to indicate a connection between the product and Grasim Industries Ltd., a well-known cement manufacturer. This usage fell within the definition of a 'trade name,' thus disqualifying the Respondents from the Notification's benefits.3. Consistency of Tribunal's Previous Judgments with Supreme Court Decisions:The Tribunal had relied on earlier judgments, including Astra Pharmaceuticals (P) Ltd. v. Collector of Central Excise, which dealt with different contexts and phrases. The Supreme Court clarified that the interpretation of 'brand name' or 'trade name' in the current context was different from 'patent or proprietary medicines' considered in Astra Pharmaceuticals. The Tribunal's reliance on Astra Pharmaceuticals was thus a misconstruction. The Supreme Court overruled the Tribunal's decisions in related cases such as Nippa Chemicals (Pvt.) Ltd. and Commissioner of Central Excise, Hyderabad v. Sarat Electronics, finding them to be based on erroneous interpretations.4. Imposition of Penalty Under Rule 173Q of the Central Excise Rules, 1944:The Commissioner had imposed a penalty of Rs. 10,00,000/- under Rule 173Q. However, the Supreme Court noted that the Tribunal had previously interpreted the Notification in a manner that could have led the Respondents to believe they were entitled to the exemption. Given this, the Supreme Court found it inappropriate to impose a penalty, as the Respondents' interpretation, although incorrect, was not unreasonable. The penalty was thus deleted.Conclusion:The Supreme Court set aside the Tribunal's judgment and restored the Commissioner's order, denying the benefit of the Notification to the Respondents. However, the imposition of the penalty was deleted due to the reasonable belief of the Respondents based on prior Tribunal interpretations. The appeals were disposed of with no order as to costs.